Literature DB >> 9484508

Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives.

D L Thai1, M T Sapko, C T Reiter, D E Bierer, J M Perel.   

Abstract

We report the first asymmetric synthesis of the individual enantiomers of methylphenidate (1). From d-pipecolic acid, the (2R,2'R) and (2S,2'R) enantiomers of 1 were obtained in > 99% optical purity while the (2S,2'S) and (2R,2'S) enantiomers of 1 were derived from l-pipecolic acid in 96% optical purity. The versatility of this methodology is demonstrated with the synthesis of the (2R,2'R) and (2S,2'S) enantiomers of p-bromo and p-methoxy derivatives in similar yields and enantiomeric purities. Comparative neurochemical assessments of these synthesized enantiomers at purported dopamine, norepinephrine, and serotonin uptake sites along with locomotor activity studies in rats are also reported.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484508     DOI: 10.1021/jm970620j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

Authors:  David J Lapinsky; Ranganadh Velagaleti; Nageswari Yarravarapu; Yi Liu; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Rejwi Acharya; Roxanne A Vaughan; Howard M Deutsch
Journal:  Bioorg Med Chem       Date:  2010-11-04       Impact factor: 3.641

2.  Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods.

Authors:  Kathleen M Gilbert; William J Skawinski; Milind Misra; Kristina A Paris; Neelam H Naik; Ronald A Buono; Howard M Deutsch; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

3.  Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate.

Authors:  David J Lapinsky; Nageswari Yarravarapu; Tammy L Nolan; Christopher K Surratt; John R Lever; Michael Tomlinson; Roxanne A Vaughan; Howard M Deutsch
Journal:  ACS Med Chem Lett       Date:  2012-03-11       Impact factor: 4.345

4.  Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Authors:  Andrea Casiraghi; Francesca Longhena; Gaia Faustini; Giovanni Ribaudo; Lorenzo Suigo; Gisela Andrea Camacho-Hernandez; Federica Bono; Viviana Brembati; Amy Hauck Newman; Alessandra Gianoncelli; Valentina Straniero; Arianna Bellucci; Ermanno Valoti
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.